2025
Annual General Meeting 2025
The Annual General Meeting of APONTIS PHARMA AG was held on Tuesday, July 29, 2025, at 10:00 a.m. (CEST).
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG):
Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to: apontis-pharma@linkmarketservices.eu.
Vote Results (German only)
Speech of the Board (German only)
Annual General Meeting 2025 Presentation (German only)
Agenda and convening of the Annual General Meeting
Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212
Annual Report 2024 incl. Group financial statements, Group management report, and report of the Supervisory Board
APONTIS PHARMA AG Individual Statements 2024 (German only)
Information on agenda item 4
Information on agenda item 6 - Squeeze-out under merger law
Merger agreement between Zentiva and Apontis dated 13 June 2025 (German only)
APONTIS PHARMA Annual financial statements 2022 (German only)
APONTIS PHARMA Annual Report 2022 (consolidated financial statements and Group management report)
APONTIS PHARMA Annual financial statements 2023 (German only)
APONTIS PHARMA Annual Report 2023 (consolidated financial statements and Group management report)
APONTIS PHARMA Annual financial statements 2024 (German only)
APONTIS PHARMA Annual Report 2024 (consolidated financial statements and Group management report)
Zentiva annual financial statements 2024 (German only)
Merger report Zentiva and APONTIS PHARMA dated 13 June 2025 (German only)
Assessment report (Merger agreement) IVA Valuation & Advisory dated 13 June 2025 (German only)
Zentiva transfer report dated 13 June 2025 (German only)
Audit report (Cash compensation) IVA Valuation & Advisory dated 13 June 2025 (German only)
APONTIS PHARMA draft transfer resolution (German only)
Declaration of Warranty BNP Bank dated 12 June 2025 (German only)
2024
Annual General Meeting 2024
The Annual General Meeting of APONTIS PHARMA AG was held on Friday, 17 May 2024, at 10:00 a.m. (CEST).
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG):
Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@linkmarketservices.eu.
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG):
Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@linkmarketservices.eu.
Vote Results
Agenda and convening of the Annual General Meeting
Information
on Agenda item 4
on Agenda item 4
Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212
Annual Report 2023 incl. Group financial statements, Group management report and report of the Supervisory Board
APONTIS PHARMA AG Individual Statements 2023 (German only)
Articles of Association (German only)
Power of attorney to Company's proxies
Power of attorney to a third person
Revocation
of a power of attorney
of a power of attorney
Notes on data protection
2023
Annual General Meeting 2023
The Annual General Meeting of APONTIS PHARMA AG was held on Friday, 12 May 2023, at 10:00 a.m. (CEST).
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG): Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@better-orange.de.
Confirmation of the counting of votes pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG): Pursuant to section 129 para. 5 sentence 1 of the German Stock Corporation Act (AktG), the person voting may request confirmation from the company within one month after the day of the Annual General Meeting as to whether and how his/her vote was counted. A request to this effect may be sent by e-mail to apontis-pharma@better-orange.de.
Votings Results – German only
Speech of the Board (German only)
Annual Report 2022 incl. Group financial statements, Group management report and report of the Supervisory Board
APONTIS PHARMA AG Individual Statements 2022 (German only)
Articles of Association (German only)
Information pursuant to Section 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018/1212
Agenda and convening of the Annual General Meeting
Information on data protection
Power of attorney to the proxies of the Company
Power of attorney to a third person
Revocation of a power of attorney
2022
Annual General Meeting 2022
The annual general meeting of APONTIS PHARMA AG was held on Thursday, May 12, 2022, at 10.00 a.m. (CEST).The Company’s annual general meeting was held in virtual form without the physical presence of the shareholders or their representatives (with the exception of the voting representatives appointed by the Company).
Votings Results – German only
Convening and agenda of the virtual AGM 2022
Information according to § 125 AktG and Table 3 Blocks A to F Implementing Regulation EU 2018_1212
Resumes Supervisory Board Candidates
Resumes Supervisory Board
Annual financial statements 2021
Annual financial statement 2021 (German only)
Articles of Association of APONTIS PHARMA AG (German only)
Proxy to a person of your choice
Power of attorney to Company's proxies
Revocation
Notes on data protection
